Work

Science@SLAC—Discovering New Drugs

Year: 2011

Type: article

Abstract: SLAC scientists and private-sector drug makers describe how a public--private partnership combined with the specialized X-rays from the Stanford Synchrotron Radiation Lightsource (SSRL) enable smart drug design that eliminates the costly trial-and-error approach used by traditional drug companies. SSRL is a synchrotron lightsource laboratory used by scientists from a range of disciplines to study matter on the scale of atoms and molecules. Featured in this video are SLAC Laboratory Director Persis Drell, SSRL staff scientist Clyde Smith, and Dave Bushnell, a scientist from startup drug maker Cocrystal Discovery Inc.

Source: OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)

Authors: P. S. Drell, Clyde A. Smith, Dave Bushnell

Language: English

Topic: Enzyme Structure and Function

Subfield: Materials Chemistry

Field: Materials Science

Domain: Physical Sciences

Open Access status: green

OpenAlex ID: W2463398007

FWCI:

Cites:

Cited by:

Related to: 4